# Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG

> **NCT03609723** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 2433 (actual)

## Conditions studied

- Complication of Coronary Artery Bypass Graft
- Complication of Extracorporeal Circulation

## Interventions

- **PROCEDURE:** CABG

## Key facts

- **NCT ID:** NCT03609723
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06-12
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 2433 (ACTUAL)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03609723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03609723, "Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03609723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*